2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | MOLECULAR THERAPY MOL THER (此期刊被最新的JCR期刊SCIE收录) LetPub评分 8.8
54人评分
我要评分
声誉 9.6 影响力 8.1 速度 9.1 | |||||||||||||||||||||||||||||||||
期刊ISSN | 1525-0016 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||||||
E-ISSN | 1525-0024 | |||||||||||||||||||||||||||||||||
2022-2023最新影响因子 (数据来源于搜索引擎) | 12.4 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||||
实时影响因子 | 截止2023年12月27日:9.636 | |||||||||||||||||||||||||||||||||
2022-2023自引率 | 3.20%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||||
五年影响因子 | 12.6 | |||||||||||||||||||||||||||||||||
h-index | 158 | |||||||||||||||||||||||||||||||||
CiteScore |
| |||||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||||
期刊官方网站 | http://www.nature.com/mt/index.html | |||||||||||||||||||||||||||||||||
期刊投稿网址 | https://www.editorialmanager.com/MOLECULAR-THERAPY | |||||||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足MOLECULAR THERAPY的语言要求,还能让MOLECULAR THERAPY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被MOLECULAR THERAPY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||||||||||||||
通讯方式 | NATURE PUBLISHING GROUP, 75 VARICK ST, 9TH FLR, NEW YORK, USA, NY, 10013-1917 | |||||||||||||||||||||||||||||||||
出版商 | Cell Press | |||||||||||||||||||||||||||||||||
涉及的研究方向 | 医学-生物工程与应用微生物 | |||||||||||||||||||||||||||||||||
出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||||
出版周期 | Monthly | |||||||||||||||||||||||||||||||||
出版年份 | 2000 | |||||||||||||||||||||||||||||||||
年文章数 | 239点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||||
Gold OA文章占比 | 88.39% | |||||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 89.12% | |||||||||||||||||||||||||||||||||
WOS期刊SCI分区 ( 2022-2023年最新版) | WOS分区等级:1区
| |||||||||||||||||||||||||||||||||
中科院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1525-0016%5BISSN%5D | |||||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: 平均1月 | |||||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: 较难 | |||||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在MOLECULAR THERAPY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | Targeting inflammatory macrophages rebuilds therapeutic efficacy of DOT1L inhibition in hepatocellular carcinoma Author: Yang, Yi-Bin; Wu, Cai-Yuan; Wang, Xu-Yan; Deng, Jia; Cao, Wen-Jie; Tang, Yun-Zhi; Wan, Chao-Chao; Chen, Zhi-Tian; Zhan, Wan-Yu; Shan, Hong; Kuang, Dong-Ming; Wei, Yuan Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 105-118. DOI: 10.1016/j.ymthe.2022.09.019 PubMed DOI |
2. | NLRC3 expression in macrophage impairs glycolysis and host immune defense by modulating the NF-KB-NFAT5 complex during septic immunosuppression Author: Xu, Jiqian; Gao, Chenggang; He, Yajun; Fang, Xiangzhi; Sun, Deyi; Peng, Zhekang; Xiao, Hairong; Sun, Miaomiao; Zhang, Pei; Zhou, Ting; Yang, Xiaobo; Yu, Yuan; Li, Ruiting; Zou, Xiaojing; Shu, Huaqing; Qiu, Yang; Zhou, Xi; Yuan, Shiying; Yao, Shanglong; Shang, You Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 154-173. DOI: 10.1016/j.ymthe.2022.08.023 PubMed DOI |
3. | MAP7D2 reduces CD8+cytotoxic T lymphocyte infiltration through MYH9-HMGB1 axis in colorectal cancer Author: Wu, Qian; Yue, Xiao; Liu, Huashan; Zhu, Yaxi; Ke, Haoxian; Yang, Xin; Yin, Shi; Li, Zhihao; Zhang, Yunfeng; Hu, Tuo; Lan, Ping; Wu, Xianrui Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 90-104. DOI: 10.1016/j.ymthe.2022.09.001 PubMed DOI |
4. | CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma Author: Wang, Guoqing; Zhang, Zongliang; Zhong, Kunhong; Wang, Zeng; Yang, Nian; Tang, Xin; Li, Hexian; Lu, Qizhong; Wu, Zhiguo; Yuan, Boyang; Zheng, Meijun; Cheng, Ping; Tong, Aiping; Zhou, Liangxue Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 134-153. DOI: 10.1016/j.ymthe.2022.08.021 PubMed DOI |
5. | A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity Author: Shi, Wenqiang; Lv, Liangyin; Liu, Nan; Wang, Hui; Wang, Yang; Zhu, Wen; Liu, Zexin; Zhu, Jianwei; Lu, Huili Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 66-77. DOI: 10.1016/j.ymthe.2022.08.016 PubMed DOI |
6. | Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma Author: Liu, Xiaoyu; Zhou, Jingying; Wu, Haoran; Chen, Shufen; Zhang, Lingyun; Tang, Wenshu; Duan, Liang; Wang, Ying; McCabe, Eleanor; Hu, Mengying; Yu, Zhuo; Liu, Hanzhuang; Choi, Chung Hang Jonathan; Sung, Joseph Jao-yiu; Huang, Leaf; Liu, Rihe; Cheng, Alfred Sze-lok Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 119-133. DOI: 10.1016/j.ymthe.2022.09.012 PubMed DOI |
7. | NAMPT is a metabolic checkpoint of IFNy-producing CD4+T cells in lupus nephritis Author: Li, Mengyuan; Lai, Yimei; Chen, Binfeng; Guo, Chaohuan; Zhou, Mianjing; Zhao, Siyuan; Wang, Shuyi; Li, Jin; Yang, Niansheng; Zhang, Hui Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 193-210. DOI: 10.1016/j.ymthe.2022.09.013 PubMed DOI |
8. | PD-1/PD-L1 blockade is a potent adjuvant in treatment of Staphylococcus aureus osteomyelitis in mice Author: Li, Kaiqun; Chen, Yuhui; Lin, Yihuang; Zhang, Guangyan; Su, Jianwen; Wu, Xiaohu; Cheng, Caiyu; Wang, Yutian; Yu, Bin; Zhang, Xianrong Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 174-192. DOI: 10.1016/j.ymthe.2022.09.006 PubMed DOI |
9. | Screening DNA aptamers that control the DNA cleavage, homology-directed repair, and transcriptional regulation of the CRISPR-(d)Cas9 system Author: Huang, Xinbo; Wang, Mingxia; Wu, Xia; Zou, Yanfen; Xu, Jinming; Cao, Congcong; Ma, Qian; Yu, Bo; Liu, Yuchen; Gui, Yaoting Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 260-268. DOI: 10.1016/j.ymthe.2022.10.009 PubMed DOI |
10. | Balancing activation and co-stimulation of CAR tunes signaling dynamics and enhances therapeutic potency Author: Duan, Yanting; Chen, Jiangqing; Meng, Xianhui; Liu, Longwei; Shang, Kai; Wu, Xiaoyan; Wang, Yajie; Huang, Zihan; Liu, Houyu; Huang, Yanjie; Zhou, Chun; Gao, Xiaofei; Wang, Yingxiao; Sun, Jie Journal: MOLECULAR THERAPY. 2023; Vol. 31, Issue 1, pp. 35-47. DOI: 10.1016/j.ymthe.2022.08.018 PubMed DOI |
|
|
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分: | |
同领域作者分享投稿经验:共188条 (包含回复) |
我来分享 |
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海分公司 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960
增值电信业务经营许可证:沪B2-20211595
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451